Evidence map›Paper›PMID 24141982›Full record

ArticleThe Journal of infectious diseases2014

Comparison of the live attenuated yellow fever vaccine 17D-204 strain to its virulent parental strain Asibi by deep sequencing.

Andrew Beck, Robert B Tesh, Thomas G Wood, Steven G Widen, Kate D Ryman, Alan D T Barrett

Abstract readComparative Study
In one paragraph

Article in The Journal of infectious diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Intra-Host Diversity of Dengue Virus in Mosquito Vectors.Frontiers in cellular and infection microbiology · 2022
    Review
  14. Article
  15. Article
  16. The Present and Future of Yellow Fever Vaccines.Pharmaceuticals (Basel, Switzerland) · 2021
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Andrew BeckDepartment of Pathology.
Robert B Tesh
Thomas G Wood
Steven G Widen
Kate D Ryman
Alan D T Barrett

Funding

Biodefense Training ProgramT32AI060549 · NIAID · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI ASHOK K CHOPRA, Janice J Endsley · 2004 to 2026
$3.0M
A Small Animal Model for Viscerotropic Disease to Improve Yellow Fever VaccineR01AI081886 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KLIMSTRA, WILLIAM B · 2011 to 2015
$1.7M
Maintenance of the virus-specific T cell equillibrium in chronic MCMV infectionK22AI081866 · NIAID · THOMAS JEFFERSON UNIVERSITY · PI SNYDER, CHRISTOPHER M · 2010 to 2011
$270k
NIAID NIH HHS HHSN272201000040INIAID NIH HHS K22 AI081866NIAID NIH HHS R01 AI081886NIAID NIH HHS T32 AI060549PHS HHS HHSN27200004/D04
6 · The paper itself

Abstract

backgroundThe first comparison of a live RNA viral vaccine strain to its wild-type parental strain by deep sequencing is presented using as a model the yellow fever virus (YFV) live vaccine strain 17D-204 and its wild-type parental strain, Asibi.

methodsThe YFV 17D-204 vaccine genome was compared to that of the parental strain Asibi by massively parallel methods. Variability was compared on multiple scales of the viral genomes. A modeled exploration of small-frequency variants was performed to reconstruct plausible regions of mutational plasticity.

resultsOvert quasispecies diversity is a feature of the parental strain, whereas the live vaccine strain lacks diversity according to multiple independent measurements. A lack of attenuating mutations in the Asibi population relative to that of 17D-204 was observed, demonstrating that the vaccine strain was derived by discrete mutation of Asibi and not by selection of genomes in the wild-type population.

conclusionsRelative quasispecies structure is a plausible correlate of attenuation for live viral vaccines. Analyses such as these of attenuated viruses improve our understanding of the molecular basis of vaccine attenuation and provide critical information on the stability of live vaccines and the risk of reversion to virulence.

Indexed as

Genome, ViralHigh-Throughput Nucleotide SequencingPolymorphism, GeneticMutationRNA, ViralYellow Fever VaccineYellow fever virusRNA, ViralYellow Fever Vaccine17D, Viral PopulationDeep SequencingFlavivirusParallel SequencingQuasispeciesVaccineVariantsYellow Fever Virus

Identifiers

PMID24141982
PMCPMC3883177

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.